Covid-19 antibodies found in 72% samples, says ICMR study | Latest News India - Hindustan Times
close_game
close_game

Covid-19 antibodies found in 72% samples, says ICMR study

Hindustan Times, New Delhi | By
Dec 04, 2020 11:03 AM IST

A total of 343 blood samples, of which 89 were positive, 58 negative for Sars-Cov-2, 17 cross-reactive, and 179 serum from healthy individuals were collected and tested at ICMR’s National Institute of Virology in Pune from March to May

Neutralising antibodies against SARS-CoV-2, which causes Covid-19, were found in 72% of the samples tested at an Indian Council of Medical Research (ICMR) institute, according to a study published in the Indian Journal of Medical Research (IJMR). The study found antibodies were also present in asymptomatic Covid-19 patients.

An ICMR team conducts surveillance at Balapur in Hyderabad.(File photo)
An ICMR team conducts surveillance at Balapur in Hyderabad.(File photo)

Neutralising antibodies defend cells from the virus.“...to say anything conclusively about protection against re-infection needs to be studied further,” said one of the authors of the study, requesting not to be identified.

Hindustan Times - your fastest source for breaking news! Read now.

A total of 343 blood samples, of which 89 were positive, 58 negative for Sars-Cov-2, 17 cross-reactive, and 179 serum from healthy individuals were collected and tested at ICMR’s National Institute of Virology in Pune from March to May.

“Among 89 serum samples from SARS-CoV-2 real-time RT-PCR confirmed patients... 64 (71.9%) were found positive and the remaining 25 serum samples (28.1%) negative,” says the study. “Of the 89 COVID-19-positive patients, 59 (66.3%) were symptomatic and 30 (33.7%) were asymptomatic.”

Also read | Covid-19: What you need to know today

Serum samples from Covid-19 confirmed patients (n=89) using real-time reverse transcription-polymerase chain reaction (RT-PCR) in Pune and Alappuzha in Kerala were taken for the study.

The symptomatic patients had cough in 48 cases (81.4%), fever in 36 (61%), sore throat in 16 (7.1%), breathlessness in 11 (18.6%), body ache in 9 (15.3%), headache in 5 (8.5%), nasal discharge 2 (3.4%) and diarrhoea in 2 (3.4%).

Of the 59 symptomatic patients, 42 (71.2%) showed the presence of antibodies. Among 30 asymptomatic patients, 22 showed them (73.3%). Among the 25 (28.1%) neutralising antibody negatives, 11 patients were positive (7 symptomatic and 4 asymptomatic), according to the researchers.

Samples were collected within 2 weeks after RT-PCR confirmation from 58 Sars-Cov-2 RT-PCR-negative patients.

“Understanding NAb [neutralising antibody] response among Covid-19 patients is a crucial requirement because the presence of neutralizing antibodies would provide greater assurance of protection in the absence of approved and validated preventive and therapeutic options… The role of cellular immune responses (T cells or cytokines) in the recovery of such patients needs to be explored,” the study says.

“More systematic studies with controlled follow up of patients and titration of NAb among the recovered patients will provide useful information for passive antibody therapy against SARS-CoV-2 virus infection. Further, it is pertinent to study the protective role of NAb during reinfection in recovered Covid-19 patients.”

Experts say that merely detecting antibodies is not enough.

“What is crucial is to know the quality of antibodies, and whether these offer immunity against the disease, and for how long,” said Dr Lalit Kant, former head, epidemiology and communicable disease division, ICMR.

Unveiling Elections 2024: The Big Picture', a fresh segment in HT's talk show 'The Interview with Kumkum Chadha', where leaders across the political spectrum discuss the upcoming general elections. Watch now!

Get Current Updates on India News, Election 2024, Arvind Kejriwal News Live, Bihar Board 10th Result 2024 Live along with Latest News and Top Headlines from India and around the world.
SHARE THIS ARTICLE ON
Share this article
  • ABOUT THE AUTHOR
    author-default-90x90

    Rhythma Kaul works as an assistant editor at Hindustan Times. She covers health and related topics, including ministry of health and family welfare, government of India.

SHARE
Story Saved
Live Score
OPEN APP
Saved Articles
Following
My Reads
Sign out
New Delhi 0C
Thursday, March 28, 2024
Start 14 Days Free Trial Subscribe Now
Follow Us On